Rahbari H, Ahmadi M, Doreh M, Mahmoudi S, Ghaemmaghami P, Fereidouni A
BMC Musculoskelet Disord. 2025; 26(1):70.
PMID: 39828687
PMC: 11744891.
DOI: 10.1186/s12891-024-08263-7.
Alotaibi S, Damfu N, Alnefaie A, Alqurashi A, Althagafi S, Alotaibi A
Pharmacy (Basel). 2024; 12(5).
PMID: 39452803
PMC: 11511332.
DOI: 10.3390/pharmacy12050147.
Caubergs V, Van den Broucke E, Mertens B, Gijsen M, Peetermans W, Van Wijngaerden E
Infection. 2024; 52(6):2297-2314.
PMID: 38967768
DOI: 10.1007/s15010-024-02279-w.
Chen Y, Song Y, Wang Z, Lai Y, Yin W, Cai Q
Cell Mol Immunol. 2024; 21(6):533-545.
PMID: 38532043
PMC: 11143357.
DOI: 10.1038/s41423-024-01152-y.
Sano H, Fukushima K, Yano M, Osone S, Kato Y, Hasegawa D
Int J Hematol. 2024; 119(6):745-754.
PMID: 38460081
DOI: 10.1007/s12185-024-03745-9.
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects.
Hodel K, Fonseca A, Barbosa I, Medina C, Alves B, Maciel C
Curr Pharm Biotechnol. 2024; 25(13):1651-1663.
PMID: 38258769
DOI: 10.2174/0113892010264503231108070917.
Factors affecting the changes in body mass index among emergency workers at the Fukushima Daiichi Nuclear Power Plant.
Tomonaga K, Ogami A, Ando H, Okubo T
Ind Health. 2023; 62(2):123-132.
PMID: 37821364
PMC: 10995666.
DOI: 10.2486/indhealth.2023-0009.
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pneumonia for Patients Who Are Morbidly Obese.
Kunz Coyne A, Orzol C, Veve M, Rybak M
Open Forum Infect Dis. 2023; 10(9):ofad454.
PMID: 37720698
PMC: 10500045.
DOI: 10.1093/ofid/ofad454.
An RNA-immunoprecipitation via CRISPR/dCas13 reveals an interaction between the SARS-CoV-2 5'UTR RNA and the process of human lipid metabolism.
Shimizu Y, Bandaru S, Hara M, Young S, Sano T, Usami K
Sci Rep. 2023; 13(1):10413.
PMID: 37369697
PMC: 10300121.
DOI: 10.1038/s41598-023-36680-6.
Insufficient Representation of Patients With Obesity in Randomized Controlled Trials Evaluating the Efficacy and Safety of Antimicrobials for Treatment of Skin and Skin Structure Infections: A Scoping Review.
Lee H, Wagner J, Vugrin M, Brandenburg R, Lee J, Miller L
Open Forum Infect Dis. 2023; 10(3):ofad144.
PMID: 36998628
PMC: 10043132.
DOI: 10.1093/ofid/ofad144.
The causal relationship between obesity and skin and soft tissue infections: A two-sample Mendelian randomization study.
Hu H, Mei J, Lin M, Wu X, Lin H, Chen G
Front Endocrinol (Lausanne). 2022; 13:996863.
PMID: 36568121
PMC: 9768473.
DOI: 10.3389/fendo.2022.996863.
Are Undernutrition and Obesity Associated with Post-Discharge Mortality and Re-Hospitalization after Hospitalization with Community-Acquired Pneumonia?.
Hegelund M, Ryrso C, Ritz C, Dungu A, Sejdic A, Jensen A
Nutrients. 2022; 14(22).
PMID: 36432592
PMC: 9697837.
DOI: 10.3390/nu14224906.
Obesity and the risk of catheter-related bloodstream infection: a systematic review and meta-analysis.
Wang Y, Xiang Q, Wu J, Xiao N, Chen J
Antimicrob Resist Infect Control. 2022; 11(1):141.
PMID: 36371230
PMC: 9652924.
DOI: 10.1186/s13756-022-01166-z.
Association of Severe Obesity and Chronic Obstructive Pulmonary Disease With Pneumonia Following Non-Cardiac Surgery.
Owusu-Bediako K, Pfaff K, Tram N, Stahl D, Tobias J, Nafiu O
J Clin Med Res. 2022; 14(6):237-243.
PMID: 35836727
PMC: 9275437.
DOI: 10.14740/jocmr4741.
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.
Singh R, Rathore S, Khan H, Karale S, Chawla Y, Iqbal K
Front Endocrinol (Lausanne). 2022; 13:780872.
PMID: 35721716
PMC: 9205425.
DOI: 10.3389/fendo.2022.780872.
No obesity paradox in patients with community-acquired pneumonia - secondary analysis of a randomized controlled trial.
Borisov A, Blum C, Christ-Crain M, Ebrahimi F
Nutr Diabetes. 2022; 12(1):12.
PMID: 35322019
PMC: 8943130.
DOI: 10.1038/s41387-022-00190-7.
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up.
Ravaglia S, De Giuseppe R, Carlucci A, Jehne S, Crescimanno G, Ahmad L
Front Cell Dev Biol. 2022; 10:793566.
PMID: 35252175
PMC: 8896115.
DOI: 10.3389/fcell.2022.793566.
Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection.
Malick A, Wang Y, Axelrad J, Salmasian H, Freedberg D
Gut Pathog. 2022; 14(1):7.
PMID: 35093158
PMC: 8799984.
DOI: 10.1186/s13099-022-00479-z.
The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids.
So M, Takahashi M, Miyamoto Y, Ishisaka Y, Iwagami M, Tsugawa Y
Diabetes Metab Syndr. 2022; 16(1):102373.
PMID: 34979344
PMC: 8714243.
DOI: 10.1016/j.dsx.2021.102373.
Effect of Obesity on Clinical Outcomes of Patients Treated With Cefepime.
Morrison A, Loper J, Barber K, Stover K, Wagner J
J Pharm Technol. 2021; 37(1):30-35.
PMID: 34752550
PMC: 7809331.
DOI: 10.1177/8755122520967398.